Fidelity Investments’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $918K | Sell |
57,437
-186,284
| -76% | -$2.98M | ﹤0.01% | 2749 |
|
|
2025
Q1 | $3.71M | Buy |
243,721
+208,234
| +587% | +$3.17M | ﹤0.01% | 2250 |
|
|
2024
Q4 | $720K | Buy |
35,487
+20,424
| +136% | +$414K | ﹤0.01% | 2783 |
|
|
2024
Q3 | $387K | Sell |
15,063
-221,665
| -94% | -$5.7M | ﹤0.01% | 2956 |
|
|
2024
Q2 | $3.04M | Sell |
236,728
-2,297
| -1% | -$29.5K | ﹤0.01% | 2227 |
|
|
2024
Q1 | $5.47M | Buy |
239,025
+133,136
| +126% | +$3.05M | ﹤0.01% | 2052 |
|
|
2023
Q4 | $2.77M | Buy |
105,889
+105,329
| +18,809% | +$2.76M | ﹤0.01% | 2230 |
|
|
2023
Q3 | $15.7K | Hold |
560
| – | – | ﹤0.01% | 3923 |
|
|
2023
Q2 | $17K | Buy |
560
+6
| +1% | +$182 | ﹤0.01% | 3933 |
|
|
2023
Q1 | $10.4K | Buy |
554
+437
| +374% | +$8.21K | ﹤0.01% | 4114 |
|
|
2022
Q4 | $1.19K | Buy |
117
+62
| +113% | +$630 | ﹤0.01% | 4617 |
|
|
2022
Q3 | $1K | Buy |
55
+43
| +358% | +$782 | ﹤0.01% | 4743 |
|
|
2022
Q2 | $1K | Sell |
12
-42
| -78% | -$3.5K | ﹤0.01% | 4806 |
|
|
2022
Q1 | $5K | Sell |
54
-216
| -80% | -$20K | ﹤0.01% | 4455 |
|
|
2021
Q4 | $41K | Sell |
270
-5,730
| -96% | -$870K | ﹤0.01% | 3285 |
|
|
2021
Q3 | $814K | Hold |
6,000
| – | – | ﹤0.01% | 2724 |
|
|
2021
Q2 | $881K | Buy |
+6,000
| New | +$881K | ﹤0.01% | 2688 |
|